<b>Phase transition and clinical outcomes of HBeAg-negative chronic hepatitis B patients </b><b>in</b><b> indeterminate phase </b><b>with normal ALT</b>

This study aimed to explore the phase transition and disease progression in hepatitis B e antigen (HBeAg) negative indeterminate phase CHB patients with normal alanine aminotransferase (ALT)